{"canonical":"https://abierto.us/opportunities/36e79725r0002","key":"36E79725R0002","url":"https://abierto.us/opportunities/36e79725r0002","title":"6505--Omeprazole Dr Capsules- NAC Repack","solicitation_number":"36E79725R0002","notice_type":"a","open":false,"response_deadline":"2024-12-27T20:30:00Z","first_posted":"2024-10-28","last_posted":"2025-01-30","department":"VETERANS AFFAIRS, DEPARTMENT OF","subagency":"VETERANS AFFAIRS, DEPARTMENT OF","office":"NAC PHARMACEUTICALS (36E797)","naics":"325412","psc":"6505","set_aside":null,"place_state":null,"place_county":null,"place_county_name":null,"place_city":null,"place_city_name":null,"winner":"GOLDEN STATE MEDICAL SUPPLY, INC.","award_amount":"0","publications":[{"notice_id":"635c2a9dd4a0463c8a12c3bdb3217df1","title":"6505--Omeprazole Dr Capsules- NAC Repack","solicitation_number":"36E79725R0002","notice_type":"p","base_type":"p","posted":"2024-10-28","posted_at":null,"due_at":"2024-11-08T20:30:00Z","due_date":"2024-11-08","cancelled":null,"archived":null,"archive_date":"2025-02-15","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/635c2a9dd4a0463c8a12c3bdb3217df1/view","enriched":false,"history":[]},{"notice_id":"2f102a161fe140f399043139930bac06","title":"6505--Omeprazole Dr Capsules- NAC Repack","solicitation_number":"36E79725R0002","notice_type":"o","base_type":"p","posted":"2024-11-14","posted_at":null,"due_at":"2024-12-03T20:30:00Z","due_date":"2024-12-03","cancelled":null,"archived":null,"archive_date":"2025-03-12","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/2f102a161fe140f399043139930bac06/view","enriched":false,"history":[]},{"notice_id":"a76d22ffb4e849b2acb01ec1656bee57","title":"6505--Omeprazole Dr Capsules- NAC Repack","solicitation_number":"36E79725R0002","notice_type":"o","base_type":"o","posted":"2024-11-27","posted_at":null,"due_at":"2024-12-10T20:30:00Z","due_date":"2024-12-10","cancelled":null,"archived":null,"archive_date":"2025-01-09","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/a76d22ffb4e849b2acb01ec1656bee57/view","enriched":false,"history":[]},{"notice_id":"6a88cd3df72149d4ba3ded987076727c","title":"6505--Omeprazole Dr Capsules- NAC Repack","solicitation_number":"36E79725R0002","notice_type":"o","base_type":"o","posted":"2024-12-19","posted_at":null,"due_at":"2024-12-27T20:30:00Z","due_date":"2024-12-27","cancelled":null,"archived":null,"archive_date":"2025-01-26","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/6a88cd3df72149d4ba3ded987076727c/view","enriched":false,"history":[]},{"notice_id":"81f5bf9caa4e4a88b955fda0bf742c1a","title":"6505--Omeprazole Dr Capsules- NAC Repack","solicitation_number":"36E79725R0002","notice_type":"a","base_type":"a","posted":"2025-01-30","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2025-03-31","award_number":"36E79725D0015","awardee_name":"GOLDEN STATE MEDICAL SUPPLY, INC. CAMARILLO 93012-8601","amount":"0","link_sam":"https://sam.gov/workspace/contract/opp/81f5bf9caa4e4a88b955fda0bf742c1a/view","enriched":false,"history":[]}],"latest_notice_id":"81f5bf9caa4e4a88b955fda0bf742c1a","first_type":"p","notices":[{"dates":{"posted":"2024-10-28","response_deadline":{"raw":"2024-11-08T14:30:00-06:00","utc":"2024-11-08T20:30:00Z","date":"2024-11-08","time":"14:30:00","utc_offset_seconds":-21600}},"links":{"sam":"https://sam.gov/workspace/contract/opp/635c2a9dd4a0463c8a12c3bdb3217df1/view"},"naics":{"codes":["325412"],"primary":"325412"},"title":"6505--Omeprazole Dr Capsules- NAC Repack","agency":{"office":{"code":"36E797","name":"NAC PHARMACEUTICALS (36E797)"},"subtier":{"code":"3600","name":"VETERANS AFFAIRS, DEPARTMENT OF"},"department":{"code":"036","name":"VETERANS AFFAIRS, DEPARTMENT OF"},"office_address":{"zip":"60141","city":"HINES","state":"IL","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2025-02-15","archive_type":"auto_custom"},"contacts":[{"name":"Teresa Hussain","role":"primary","email":"teresa.hussain@va.gov","phone":"708-786-5852","title":"Contract Specialist"}],"base_type":{"code":"p","label":"Presolicitation"},"notice_id":"635c2a9dd4a0463c8a12c3bdb3217df1","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2025_archived_opportunities.csv","etag":"\"d47226e3d2c6545974b252e103f82b34-139\"","fetched_at":"2026-09-16T19:12:38.374141Z","row_sha256":"48869d5e5811c87bf021d7aec21d77a2bef1845ac10c6d5f97adb434cd224168","last_modified":"2026-09-13T14:49:20Z"},"updated_at":"2026-09-16T19:12:38.374141Z","first_seen_at":"2026-09-16T19:12:38.374141Z"},"description":{"text":"PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0002 for an unrestricted procurement for Omeprazole DR Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract per Group; two Groups will be awarded, to the responsible offeror(s) who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA Pharmaceutical Prime Vendor Programs for Other Government Agencies and through the Repackaging Program for VA. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 and 4, 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79725R0002 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about November 19, 2024, with a tentative closing date of December 3, 2024. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Teresa Hussain. Questions can be e-mailed to Teresa.Hussain@va.gov The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION Â GROUP 1 - OGA Â Â ITEM DESCRIPTION PKG SZ (CAPS PER BT) TOTAL EST ANNUAL USAGE (BT) 1 OMEPRAZOLE DR 20 MG CAPSULE 90 237 2 OMEPRAZOLE DR 20 MG CAPSULE 100 1,365 3a OMEPRAZOLE DR 20 MG CAPSULE 500 36,416 OR OR OR OR 3b OMEPRAZOLE DR 20 MG CAPSULE 1000 18,208 4 OMEPRAZOLE DR 40 MG CAPSULE 90 561 5 OMEPRAZOLE DR 40 MG CAPSULE 100 563 6a OMEPRAZOLE DR 40 MG CAPSULE 500 11,688 OR OR OR OR 6b OMEPRAZOLE DR 40 MG CAPSULE 1000 5,844 Â GROUP 2 - VA ITEM VA REPACK PROGRAM TOTAL EST ANNUAL USAGE CAPS - BULK 1 OMEPRAZOLE 20MG CAP,EC 248,000,000 2 OMEPRAZOLE 40MG CAP,EC 51,000,000","origin":"extract"},"notice_type":{"code":"p","label":"Presolicitation"},"schema_version":1,"solicitation_number":"36E79725R0002","product_service_code":"6505"},{"dates":{"posted":"2024-11-14","response_deadline":{"raw":"2024-12-03T14:30:00-06:00","utc":"2024-12-03T20:30:00Z","date":"2024-12-03","time":"14:30:00","utc_offset_seconds":-21600}},"links":{"sam":"https://sam.gov/workspace/contract/opp/2f102a161fe140f399043139930bac06/view"},"naics":{"codes":["325412"],"primary":"325412"},"title":"6505--Omeprazole Dr Capsules- NAC Repack","agency":{"office":{"code":"36E797","name":"NAC PHARMACEUTICALS (36E797)"},"subtier":{"code":"3600","name":"VETERANS AFFAIRS, DEPARTMENT OF"},"department":{"code":"036","name":"VETERANS AFFAIRS, DEPARTMENT OF"},"office_address":{"zip":"60141","city":"HINES","state":"IL","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2025-03-12","archive_type":"auto_custom"},"contacts":[{"name":"Teresa Hussain","role":"primary","email":"teresa.hussain@va.gov","title":"Senior Contract Specialist"}],"base_type":{"code":"p","label":"Presolicitation"},"notice_id":"2f102a161fe140f399043139930bac06","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2025_archived_opportunities.csv","etag":"\"d47226e3d2c6545974b252e103f82b34-139\"","fetched_at":"2026-09-16T19:12:38.374141Z","row_sha256":"3b2d285ebe94156479ce3e091d13e6410b3b2e632084a3c53e4a474cff5550ed","last_modified":"2026-09-13T14:49:20Z"},"updated_at":"2026-09-16T19:12:38.374141Z","first_seen_at":"2026-09-16T19:12:38.374141Z"},"description":{"text":"N/A","origin":"extract"},"notice_type":{"code":"o","label":"Solicitation"},"schema_version":1,"solicitation_number":"36E79725R0002","product_service_code":"6505"},{"dates":{"posted":"2024-11-27","response_deadline":{"raw":"2024-12-10T14:30:00-06:00","utc":"2024-12-10T20:30:00Z","date":"2024-12-10","time":"14:30:00","utc_offset_seconds":-21600}},"links":{"sam":"https://sam.gov/workspace/contract/opp/a76d22ffb4e849b2acb01ec1656bee57/view"},"naics":{"codes":["325412"],"primary":"325412"},"title":"6505--Omeprazole Dr Capsules- NAC Repack","agency":{"office":{"code":"36E797","name":"NAC PHARMACEUTICALS (36E797)"},"subtier":{"code":"3600","name":"VETERANS AFFAIRS, DEPARTMENT OF"},"department":{"code":"036","name":"VETERANS AFFAIRS, DEPARTMENT OF"},"office_address":{"zip":"60141","city":"HINES","state":"IL","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2025-01-09","archive_type":"auto_custom"},"contacts":[{"name":"Teresa Hussain","role":"primary","email":"teresa.hussain@va.gov","title":"Senior Contract Specialist"}],"base_type":{"code":"o","label":"Solicitation"},"notice_id":"a76d22ffb4e849b2acb01ec1656bee57","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2025_archived_opportunities.csv","etag":"\"d47226e3d2c6545974b252e103f82b34-139\"","fetched_at":"2026-09-16T19:12:38.374141Z","row_sha256":"06e9534912416b152cefb67e1b2e2e40da1c3eca62e7e52fcce6751ee82afc99","last_modified":"2026-09-13T14:49:20Z"},"updated_at":"2026-09-16T19:12:38.374141Z","first_seen_at":"2026-09-16T19:12:38.374141Z"},"description":{"text":"See Omeprazole National Procurement issued 11/14/2024","origin":"extract"},"notice_type":{"code":"o","label":"Solicitation"},"schema_version":1,"solicitation_number":"36E79725R0002","product_service_code":"6505"},{"dates":{"posted":"2024-12-19","response_deadline":{"raw":"2024-12-27T14:30:00-06:00","utc":"2024-12-27T20:30:00Z","date":"2024-12-27","time":"14:30:00","utc_offset_seconds":-21600}},"links":{"sam":"https://sam.gov/workspace/contract/opp/6a88cd3df72149d4ba3ded987076727c/view"},"naics":{"codes":["325412"],"primary":"325412"},"title":"6505--Omeprazole Dr Capsules- NAC Repack","agency":{"office":{"code":"36E797","name":"NAC PHARMACEUTICALS (36E797)"},"subtier":{"code":"3600","name":"VETERANS AFFAIRS, DEPARTMENT OF"},"department":{"code":"036","name":"VETERANS AFFAIRS, DEPARTMENT OF"},"office_address":{"zip":"60141","city":"HINES","state":"IL","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2025-01-26","archive_type":"auto_custom"},"contacts":[{"name":"Teresa Hussain","role":"primary","email":"teresa.hussain@va.gov","title":"Senior Contract Specialist"}],"base_type":{"code":"o","label":"Solicitation"},"notice_id":"6a88cd3df72149d4ba3ded987076727c","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2025_archived_opportunities.csv","etag":"\"d47226e3d2c6545974b252e103f82b34-139\"","fetched_at":"2026-09-16T19:12:38.374141Z","row_sha256":"786472cb9744d962bb2e8db6e2d5e0e60c6c686b77509a94f590523f6648e2f7","last_modified":"2026-09-13T14:49:20Z"},"updated_at":"2026-09-16T19:12:38.374141Z","first_seen_at":"2026-09-16T19:12:38.374141Z"},"description":{"text":"Page 5 of 89 Continuation of SF-1449, Block 3: The following information shall be entered by the Contracting Officer at the time of contract award according to the timeframes specified in this solicitation s Section B, Scope of Contract, Section 1.4 Contract Effective Date, Implementation Period, and Ordering Period. Contract Award/Effective Date: ___________________ Implementation Period: __________________________ Ordering Period (Base Year): _____________________ Offerors shall not enter information into the above fields. Continuation of SF-1449, Blocks 19 through 24: Group 1 (line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b), and Group 2 (line items 1 and 2) represent two separate requirements for purposes of FAR Clause 52.217-9, Option to Extend the Terms of the Contract and Clause 52.233-2 Service of Protest . For the purpose of determining the lowest-priced, technically acceptable offer(s) the Government will evaluate each group separately. To be considered for award for Group 1, offerors are required to submit prices for Group 1 line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b for the base and all four option years. To be considered for award for Group 2, offerors are required to submit prices for Group 2 line item 1 and 2 for the base and all four option years. Offered prices shall not exceed two decimal places. Award will be made in the aggregate for Group 1 (line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b); and Group 2, (line items 1 and 2). The Government may award two separate contracts for Group 1 and Group 2, or one contract for both groups. Line items 1 and 4 are unit of use. All unit-of-use packaging identified in the Schedule of Supplies (i.e., 90s) shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Note: NDC is defined as National Drug Code. ANDA is defined as Abbreviated New Drug Application Group 1 (OGAs) Line Item 1 - Omeprazole DR 20mg Capsules, 90 Capsules per Bottle (Unit of Use) NDC # __________________ ANDA#______________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 238 Bottles Option Year One 238 Bottles Option Year Two 238 Bottles Option Year Three 238 Bottles Option Year Four 238 Bottles Line Item 2 -Omeprazole DR 20mg Capsules, 100 Capsules per Bottle NDC # __________________ ANDA#__________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 1,633 Bottles Option Year One 1,633 Bottles Option Year Two 1,633 Bottles Option Year Three 1,633 Bottles Option Year Four 1,633 Bottles 3a OR 3b Line Item 3a - Omeprazole DR 20mg Capsules, 500 Capsules per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 36,848 Bottles Option Year One 36,848 Bottles Option Year Two 36,848 Bottles Option Year Three 36,848 Bottles Option Year Four 36,848 Bottles OR Line Item 3b - Omeprazole DR 20mg Capsules, 1000 Capsules per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 18,424 Bottles Option Year One 18,424 Bottles Option Year Two 18,424 Bottles Option Year Three 18,424 Bottles Option Year Four 18,424 Bottles Line Item 4 - Omeprazole DR 40mg Capsules, 90 Capsules per Bottle (Unit of Use) NDC # _______________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 562 Bottles Option Year One 562 Bottles Option Year Two 562 Bottles Option Year Three 562 Bottles Option Year Four 562 Bottles Line Item 5 -Omeprazole DR 40mg Capsules, 100 Capsules per Bottle NDC # __________________ ANDA#___________________________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 592 Bottles Option Year One 592 Bottles Option Year Two 592 Bottles Option Year Three 592 Bottles Option Year Four 592 Bottles 6a OR 6b Line Item 6a - Omeprazole DR 40mg Capsules, 500 Capsules per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 11,728 Bottles Option Year One 11,728 Bottles Option Year Two 11,728 Bottles Option Year Three 11,728 Bottles Option Year Four 11,728 Bottles OR Line Item 6b - Omeprazole DR 40mg Capsules, 1000 Capsules per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 5,864 Bottles Option Year One 5,864 Bottles Option Year Two 5,864 Bottles Option Year Three 5,864 Bottles Option Year Four 5,864 Bottles Group 2 (VA) Line Item 1 - Omeprazole DR 20mg Capsules, Bulk NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Drum or PKG Size Base Year 272,800,000 Capsules Option Year One 272,800,000 Capsules Option Year Two 272,800,000 Capsules Option Year Three 272,800,000 Capsules Option Year Four 272,800,000 Capsules Line Item 2 - Omeprazole DR 40mg Capsules, Bulk NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Drum or PKG Size Base Year 61,000,000 Capsules Option Year One 61,000,000 Capsules Option Year Two 61,000,000 Capsules Option Year Three 61,000,000 Capsules Option Year Four 61,000,000 Capsules ** The minimum package size for Group 2 (bulk) is 1,000 tablet count. The 1,000 tablet count will be accepted for Group 2 but a larger package size such as 10,000 Tablet drums or larger are desired for the bulk (See Section 1.5 in the Scope of Contract section of this solicitation) For each of the drug strengths listed in Group 2. For the base year only or earlier, if an offeror is not able to provide the drug in larger quantities i.e. 10,000 Tablet drums or larger, VA will accept 1,000 count bottles. When VA exercises the first option year, the successful offeror awarded the contract under this solicitation must provide in quantities of at 10,000 count drums for each of the strengths. For the purpose of evaluating offers, $0.0314 (VA awarded repackaging fee) per bottle will be added if the bottle is under 10,000 tablet count required to meet the estimated annual requirements. For example, if 1000 count bottles were proposed for Group 2, item 2 (which has estimated annual requirements of 51,000,000 capsules), $.0314 would be multiplied by 51,000. This figure would be added to the total annual price for price evaluation purposes. The $0.0314 per bottle represents the repackaging cost to the Government during the base year of contract performance for a contract awarded under this solicitation and will be included in the calculation of the lowest total aggregate price for evaluation of award. ** The estimated annual usage cited above is the Government s total estimated usage for the strength and bottle size/capsule count listed. There is no expressed or implied guarantee that the estimated quantities will be purchased under this contract. Actual quantities purchased may exceed or be less than those represented. ***Bulk Product (GROUP 2) must have at least 18 months of dating prior to product expiration on the date of shipment from the contract holder to the Pharmaceutical Repackager. ****Price Evaluation note: GROUP 1 will be evaluated based on unit prices (per bottle price) GROUP 2 will be evaluated based on unit prices (per capsule price) + 0.0314 if the tablet count is 1,000 as described above.","origin":"extract"},"notice_type":{"code":"o","label":"Solicitation"},"schema_version":1,"solicitation_number":"36E79725R0002","product_service_code":"6505"},{"award":{"date":"2025-01-30","amount":"0","number":"36E79725D0015","awardee":{"raw":"GOLDEN STATE MEDICAL SUPPLY, INC. CAMARILLO 93012-8601","name":"GOLDEN STATE MEDICAL SUPPLY, INC. CAMARILLO 93012-8601"}},"dates":{"posted":"2025-01-30","award_date":"2025-01-30"},"links":{"sam":"https://sam.gov/workspace/contract/opp/81f5bf9caa4e4a88b955fda0bf742c1a/view"},"naics":{"codes":["325412"],"primary":"325412"},"title":"6505--Omeprazole Dr Capsules- NAC Repack","agency":{"office":{"code":"36E797","name":"NAC PHARMACEUTICALS (36E797)"},"subtier":{"code":"3600","name":"VETERANS AFFAIRS, DEPARTMENT OF"},"department":{"code":"036","name":"VETERANS AFFAIRS, DEPARTMENT OF"},"office_address":{"zip":"60141","city":"HINES","state":"IL","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2025-03-31","archive_type":"auto_custom"},"contacts":[{"name":"Teresa Hussain","role":"primary","email":"teresa.hussain@va.gov","phone":"708-786-5852","title":"Senior Contract Specialist"}],"base_type":{"code":"a","label":"Award Notice"},"notice_id":"81f5bf9caa4e4a88b955fda0bf742c1a","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2025_archived_opportunities.csv","etag":"\"d47226e3d2c6545974b252e103f82b34-139\"","fetched_at":"2026-09-16T17:45:50.850439Z","row_sha256":"5af6a1b405c2895dddab90db422cac0c2467c8d78b4ee087ba61f2ee3b5c3368","last_modified":"2026-09-13T14:49:20Z"},"updated_at":"2026-09-16T17:45:50.850439Z","first_seen_at":"2026-09-16T17:45:50.850439Z"},"notice_type":{"code":"a","label":"Award Notice"},"schema_version":1,"solicitation_number":"36E79725R0002","product_service_code":"6505"}],"due_at":"2024-12-27T20:30:00Z","due_date":"2024-12-27","closes_at":"2024-12-27T20:30:00Z","awardable":false,"dept_key":"d-036","dept_name":"VETERANS AFFAIRS, DEPARTMENT OF","sub_key":"s-3600","sub_name":"VETERANS AFFAIRS, DEPARTMENT OF","office_key":"o-36E797","office_name":"NAC PHARMACEUTICALS (36E797)","state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":null,"winner_key":"GQLDJJ8AQNN5","amount":"0","linked_awards":5,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z","principal_notice_id":"6a88cd3df72149d4ba3ded987076727c","description":{"text":"Page 5 of 89 Continuation of SF-1449, Block 3: The following information shall be entered by the Contracting Officer at the time of contract award according to the timeframes specified in this solicitation s Section B, Scope of Contract, Section 1.4 Contract Effective Date, Implementation Period, and Ordering Period. Contract Award/Effective Date: ___________________ Implementation Period: __________________________ Ordering Period (Base Year): _____________________ Offerors shall not enter information into the above fields. Continuation of SF-1449, Blocks 19 through 24: Group 1 (line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b), and Group 2 (line items 1 and 2) represent two separate requirements for purposes of FAR Clause 52.217-9, Option to Extend the Terms of the Contract and Clause 52.233-2 Service of Protest . For the purpose of determining the lowest-priced, technically acceptable offer(s) the Government will evaluate each group separately. To be considered for award for Group 1, offerors are required to submit prices for Group 1 line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b for the base and all four option years. To be considered for award for Group 2, offerors are required to submit prices for Group 2 line item 1 and 2 for the base and all four option years. Offered prices shall not exceed two decimal places. Award will be made in the aggregate for Group 1 (line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b); and Group 2, (line items 1 and 2). The Government may award two separate contracts for Group 1 and Group 2, or one contract for both groups. Line items 1 and 4 are unit of use. All unit-of-use packaging identified in the Schedule of Supplies (i.e., 90s) shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Note: NDC is defined as National Drug Code. ANDA is defined as Abbreviated New Drug Application Group 1 (OGAs) Line Item 1 - Omeprazole DR 20mg Capsules, 90 Capsules per Bottle (Unit of Use) NDC # __________________ ANDA#______________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 238 Bottles Option Year One 238 Bottles Option Year Two 238 Bottles Option Year Three 238 Bottles Option Year Four 238 Bottles Line Item 2 -Omeprazole DR 20mg Capsules, 100 Capsules per Bottle NDC # __________________ ANDA#__________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 1,633 Bottles Option Year One 1,633 Bottles Option Year Two 1,633 Bottles Option Year Three 1,633 Bottles Option Year Four 1,633 Bottles 3a OR 3b Line Item 3a - Omeprazole DR 20mg Capsules, 500 Capsules per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 36,848 Bottles Option Year One 36,848 Bottles Option Year Two 36,848 Bottles Option Year Three 36,848 Bottles Option Year Four 36,848 Bottles OR Line Item 3b - Omeprazole DR 20mg Capsules, 1000 Capsules per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 18,424 Bottles Option Year One 18,424 Bottles Option Year Two 18,424 Bottles Option Year Three 18,424 Bottles Option Year Four 18,424 Bottles Line Item 4 - Omeprazole DR 40mg Capsules, 90 Capsules per Bottle (Unit of Use) NDC # _______________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 562 Bottles Option Year One 562 Bottles Option Year Two 562 Bottles Option Year Three 562 Bottles Option Year Four 562 Bottles Line Item 5 -Omeprazole DR 40mg Capsules, 100 Capsules per Bottle NDC # __________________ ANDA#___________________________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 592 Bottles Option Year One 592 Bottles Option Year Two 592 Bottles Option Year Three 592 Bottles Option Year Four 592 Bottles 6a OR 6b Line Item 6a - Omeprazole DR 40mg Capsules, 500 Capsules per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 11,728 Bottles Option Year One 11,728 Bottles Option Year Two 11,728 Bottles Option Year Three 11,728 Bottles Option Year Four 11,728 Bottles OR Line Item 6b - Omeprazole DR 40mg Capsules, 1000 Capsules per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 5,864 Bottles Option Year One 5,864 Bottles Option Year Two 5,864 Bottles Option Year Three 5,864 Bottles Option Year Four 5,864 Bottles Group 2 (VA) Line Item 1 - Omeprazole DR 20mg Capsules, Bulk NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Drum or PKG Size Base Year 272,800,000 Capsules Option Year One 272,800,000 Capsules Option Year Two 272,800,000 Capsules Option Year Three 272,800,000 Capsules Option Year Four 272,800,000 Capsules Line Item 2 - Omeprazole DR 40mg Capsules, Bulk NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Drum or PKG Size Base Year 61,000,000 Capsules Option Year One 61,000,000 Capsules Option Year Two 61,000,000 Capsules Option Year Three 61,000,000 Capsules Option Year Four 61,000,000 Capsules ** The minimum package size for Group 2 (bulk) is 1,000 tablet count. The 1,000 tablet count will be accepted for Group 2 but a larger package size such as 10,000 Tablet drums or larger are desired for the bulk (See Section 1.5 in the Scope of Contract section of this solicitation) For each of the drug strengths listed in Group 2. For the base year only or earlier, if an offeror is not able to provide the drug in larger quantities i.e. 10,000 Tablet drums or larger, VA will accept 1,000 count bottles. When VA exercises the first option year, the successful offeror awarded the contract under this solicitation must provide in quantities of at 10,000 count drums for each of the strengths. For the purpose of evaluating offers, $0.0314 (VA awarded repackaging fee) per bottle will be added if the bottle is under 10,000 tablet count required to meet the estimated annual requirements. For example, if 1000 count bottles were proposed for Group 2, item 2 (which has estimated annual requirements of 51,000,000 capsules), $.0314 would be multiplied by 51,000. This figure would be added to the total annual price for price evaluation purposes. The $0.0314 per bottle represents the repackaging cost to the Government during the base year of contract performance for a contract awarded under this solicitation and will be included in the calculation of the lowest total aggregate price for evaluation of award. ** The estimated annual usage cited above is the Government s total estimated usage for the strength and bottle size/capsule count listed. There is no expressed or implied guarantee that the estimated quantities will be purchased under this contract. Actual quantities purchased may exceed or be less than those represented. ***Bulk Product (GROUP 2) must have at least 18 months of dating prior to product expiration on the date of shipment from the contract holder to the Pharmaceutical Repackager. ****Price Evaluation note: GROUP 1 will be evaluated based on unit prices (per bottle price) GROUP 2 will be evaluated based on unit prices (per capsule price) + 0.0314 if the tablet count is 1,000 as described above.","html":null,"origin":"extract"},"contacts":[{"name":"Teresa Hussain","role":"primary","email":"teresa.hussain@va.gov","phone":"708-786-5852","title":"Senior Contract Specialist"}],"place_of_performance":null,"office_address":{"zip":"60141","city":"HINES","state":"IL","country":"USA"},"naics_codes":["325412"],"award":null,"attachments":[],"awards":[{"award_key":"CONT_IDV_36E79725D0015_3600","permalink":"https://www.usaspending.gov/award/CONT_IDV_36E79725D0015_3600/","piid":"36E79725D0015","parent_piid":null,"award_type":null,"vendor_key":"GQLDJJ8AQNN5","recipient_name":"GOLDEN STATE MEDICAL SUPPLY, INC.","recipient_uei":"GQLDJJ8AQNN5","recipient_cage":"1HT23","recipient_city":"CAMARILLO","recipient_state":"CA","sub_name":"Department of Veterans Affairs","office_name":"NAC PHARMACEUTICALS (36E797)","office_key":"o-36E797","first_action_date":"2025-01-30","last_action_date":"2026-05-12","actions":8,"obligated":"0","current_total_value":null,"potential_total_value":"56652371.05","naics":"325412","psc":"6505","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":4,"description":"NEW AWARD FOR OMEPRAZOLE DR CAPSULES WITH GOLDEN STATE MEDICAL SUPPLY, INC. ORDERING PERIOD IS 04/01/2025 - 03/31/2026 WITH FOUR, ONE-YEAR OPTION PERIODS.","method":"piid","confidence":"high","evidence":["award number 36E79725D0015 equals the contract number","same awarding office 36E797"],"opportunity_key":null,"opportunity_title":null}],"related":[{"key":"36E79726R0028","latest_notice_id":"d5658fe117a145ae92d6b84e1b53d850","title":"6505--Ticagrelor Tablets","solicitation_number":"36E79726R0028","notice_type":"o","first_type":"p","first_posted":"2026-07-30","last_posted":"2026-09-09","notices":4,"due_at":"2026-09-17T19:30:00Z","due_date":"2026-09-17","closes_at":"2026-09-17T19:30:00Z","awardable":true,"open":true,"dept_key":"d-036","dept_name":"VETERANS AFFAIRS, DEPARTMENT OF","sub_key":"s-3600","sub_name":"VETERANS AFFAIRS, DEPARTMENT OF","office_key":"o-36E797","office_name":"NAC PHARMACEUTICALS (36E797)","naics":"325412","psc":"6505","set_aside":null,"state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":null,"winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"},{"key":"36E79726Q0005","latest_notice_id":"56fa1cf0b4c9407183f5a9b8418504c8","title":"Roflumilast Tablets (VA-27-00006601)","solicitation_number":"36E79726Q0005","notice_type":"r","first_type":"r","first_posted":"2026-09-09","last_posted":"2026-09-09","notices":1,"due_at":"2026-09-17T19:30:00Z","due_date":"2026-09-17","closes_at":"2026-09-17T19:30:00Z","awardable":true,"open":true,"dept_key":"d-036","dept_name":"VETERANS AFFAIRS, DEPARTMENT OF","sub_key":"s-3600","sub_name":"VETERANS AFFAIRS, DEPARTMENT OF","office_key":"o-36E797","office_name":"NAC PHARMACEUTICALS (36E797)","naics":"325412","psc":"6505","set_aside":null,"state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":null,"winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"},{"key":"36E79726R0035","latest_notice_id":"9e06051f05fa435d8f866aa1d267ca46","title":"6505--2027-2028 Influenza Virus Vaccine","solicitation_number":"36E79726R0035","notice_type":"o","first_type":"p","first_posted":"2026-08-25","last_posted":"2026-09-08","notices":2,"due_at":"2026-09-23T19:30:00Z","due_date":"2026-09-23","closes_at":"2026-09-23T19:30:00Z","awardable":true,"open":true,"dept_key":"d-036","dept_name":"VETERANS AFFAIRS, DEPARTMENT OF","sub_key":"s-3600","sub_name":"VETERANS AFFAIRS, DEPARTMENT OF","office_key":"o-36E797","office_name":"NAC PHARMACEUTICALS (36E797)","naics":"325412","psc":"6505","set_aside":null,"state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"},{"key":"36E79726R0032","latest_notice_id":"f6fd014334c642a69af2341f78fb03fc","title":"36E79726R0032 Lisinopril Tablets (VA-27-00004937)","solicitation_number":"36E79726R0032","notice_type":"o","first_type":"p","first_posted":"2026-08-17","last_posted":"2026-09-03","notices":2,"due_at":"2026-09-24T19:30:00Z","due_date":"2026-09-24","closes_at":"2026-09-24T19:30:00Z","awardable":true,"open":true,"dept_key":"d-036","dept_name":"VETERANS AFFAIRS, DEPARTMENT OF","sub_key":"s-3600","sub_name":"VETERANS AFFAIRS, DEPARTMENT OF","office_key":"o-36E797","office_name":"NAC PHARMACEUTICALS (36E797)","naics":"325412","psc":"6505","set_aside":null,"state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":null,"winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"}]}